Research

Focus on the pharmaceutical and biotech industry
Hemophilia Explained

Hemophilia Explained

Joe Pugliese of the Hemophilia Alliance, a not-for-profit organization of federally funded hemophilia treatment centers that is working to ensure its member have the expertise, resources and public support to sustain their integrated clinical and pharmacy services for persons with hemophilia and other bleeding disorders.

Gene Therapy for Hurler Syndrome

Gene Therapy for Hurler Syndrome

Bobby Gasper, MD Chief Scientific Officer of Orchard Therapeutics, discussuses his company’s gene therapy being developed for MPS I.

Huntington’s Disease Drug Development and Patient Groups

Huntington’s Disease Drug Development and Patient Groups

Scott Schobel, MD, MSc, clinical science leader for Roche’s Huntington Disease Program talks about the role that Huntington disease patient group, throughout the world, helped Roche develop their clinical program focused on Huntington disease.

Talking to Patient Groups is Good Business

Talking to Patient Groups is Good Business

At Ovid Therapeutics, the patients’ input is essential to how they develop medications and how they do business. Leading that mindset is Luke Rosen, Patient Engagement & Digital Health Experience Head for the company.

  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.